Literature DB >> 18382075

Food and drug interaction: consequences for the nutrition/health status.

Dieter Genser1.   

Abstract

Food-drug interactions are defined as alterations of pharmacokinetics or pharmacodynamics of a drug or nutritional element or a compromise in nutritional status as a result of the addition of a drug. Elderly patients are particularly at risk because more than 30% of all the prescription drugs are taken by this population. Failure to identify and properly manage drug-nutrient interactions can lead to serious consequences. For instance, drug-nutrient interactions can result in reduced absorption of certain oral antibiotics and may lead to suboptimal antibiotic concentrations at the site of infection. This predisposes the patient to treatment failure. Induction or inhibition of enzymes in the gut by nutrients may lead to a significant change in oral bioavailability of drugs or vice versa. For example, grapefruit juice is a selective intestinal CYP3A4 inhibitor. The overall exposure of some drugs can be increased by more than fivefold when taken with grapefruit juice and increase the risk of adverse effects. The use of certain drugs may affect GI tract function and may lead to a loss of bodily electrolytes and fluid. Limiting drug prescriptions to essential medications for as short a period as possible and periodic re-evaluations of the treatment chosen are essential to minimize adverse drug-nutrient interactions. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382075     DOI: 10.1159/000115345

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  26 in total

Review 1.  Zinc: dietary intake and impact of supplementation on immune function in elderly.

Authors:  Eugenio Mocchegiani; Javier Romeo; Marco Malavolta; Laura Costarelli; Robertina Giacconi; Ligia-Esperanza Diaz; Ascension Marcos
Journal:  Age (Dordr)       Date:  2012-01-06

Review 2.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

Review 3.  Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Authors:  David G Bailey; George Dresser; J Malcolm O Arnold
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

4.  In vitro antagonistic inhibitory effects of palm seed crude oils and their main constituent, lauric acid, with oxacillin in Staphylococcus aureus.

Authors:  Klara Lalouckova; Eva Skrivanova; Johana Rondevaldova; Adela Frankova; Josef Soukup; Ladislav Kokoska
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

Review 5.  Sweet potato for type 2 diabetes mellitus.

Authors:  Cheow Peng Ooi; Seng Cheong Loke
Journal:  Cochrane Database Syst Rev       Date:  2013-09-03

Review 6.  Nonalcoholic fatty liver disease and aging: epidemiology to management.

Authors:  Marco Bertolotti; Amedeo Lonardo; Chiara Mussi; Enrica Baldelli; Elisa Pellegrini; Stefano Ballestri; Dante Romagnoli; Paola Loria
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

7.  Food-drug interactions.

Authors:  Rabia Bushra; Nousheen Aslam; Arshad Yar Khan
Journal:  Oman Med J       Date:  2011-03

8.  Polypharmacy and nutritional status in older adults: a cross-sectional study.

Authors:  Roschelle A Heuberger; Karly Caudell
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

Review 9.  Inflammation and colorectal cancer, when microbiota-host mutualism breaks.

Authors:  Marco Candela; Silvia Turroni; Elena Biagi; Franck Carbonero; Simone Rampelli; Carla Fiorentini; Patrizia Brigidi
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

Review 10.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.